Bay Harbor Wealth Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69 Hold
2
﹤0.01% 1250
2026
Q1
$47 Buy
+2
New +$55 ﹤0.01% 1258

Other funds holding BEAM

Bay Harbor Wealth Management's BEAM Position: Q2 2026 in Review

Bay Harbor Wealth Management held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 2 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Bay Harbor Wealth Management first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Bay Harbor Wealth Management held 2 shares of Beam Therapeutics worth $69 as of Q2 2026.
  • Bay Harbor Wealth Management left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1250 holding.
  • Bay Harbor Wealth Management first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.